Empyrean Neuroscience

Empyrean Neuroscience is a gene engineering company developing a series of neuroactive therapies for the treatment of various psychiatric and neurological disorders. Empyrean is leveraging the power of genetic engineering to transform how we treat severe neuropsychiatric and neurological conditions. We have developed the first and only platform for genetically engineering small-molecule therapies derived from fungi and plants. Through precise genetic modification, transformation, and regeneration of fungi and plants, this platform enables the creation of small-molecule therapies. Additionally, the platform is capable of discovering novel small molecules that may possess therapeutic properties.